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Abstract
Consumption of calorie-containing sugars elicits appetitive behavioral responses and dopamine release in the ventral
striatum, even in the absence of sweet-taste transduction machinery. However, it is unclear if such reward-related
postingestive effects reflect preabsorptive or postabsorptive events. In support of the importance of postabsorptive glucose
detection, we found that, in rat behavioral tests, high concentration glucose solutions administered in the jugular vein were
sufficient to condition a side-bias. Additionally, a lower concentration glucose solution conditioned robust behavioral
responses when administered in the hepatic-portal, but not the jugular vein. Furthermore, enteric administration of glucose
at a concentration that is sufficient to elicit behavioral conditioning resulted in a glycemic profile similar to that observed
after administration of the low concentration glucose solution in the hepatic-portal, but not jugular vein. Finally using fast-
scan cyclic voltammetry we found that, in accordance with behavioral findings, a low concentration glucose solution caused
an increase in spontaneous dopamine release events in the nucleus accumbens shell when administered in the hepatic-
portal, but not the jugular vein. These findings demonstrate that the postabsorptive effects of glucose are sufficient for the
postingestive behavioral and dopaminergic reward-related responses that result from sugar consumption. Furthermore,
glycemia levels in the hepatic-portal venous system contribute more significantly for this effect than systemic glycemia,
arguing for the participation of an intra-abdominal visceral sensor for glucose.
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Introduction
The positive postingestive consequences of food consumption
are a critical determinant of feeding behavior [1]. In fact, we
recently found that in a two-bottle behavioral paradigm, even in
animals in which functional sweet-taste transduction pathways are
absent, oral consumption of sucrose (a calorie-containing saccha-
ride), but not sucralose (a non-caloric artificial sweetener), was
sufficient for the conditioning of robust side-preferences [2].
Furthermore, when such animals ingested sucrose, increases of
dopamine release and neuronal activation were found in the
nucleus accumbens (NAcc). Postingestive-dependent stimulation of
the dopamine system has also been suggested in a human
functional imaging study, in which sucralose and sucrose where
presented at taste-intensity-paired concentrations, and only the
latter activated dopaminergic midbrain areas [3]. The relevance of
dopaminergic activation for postingestive-dependent learning has
been confirmed in experiments conducted in rats, in which
dopamine receptor antagonism in the NAcc inhibited the
development of associations between non-caloric flavors and
glucose injected directly into the duodenum [4].
With regard to the mechanisms leading to the behavioral
reward-related effects of postingestive stimulation by sugars such
as sucrose, the available data are not completely consistent. One
study has indicated that direct stimulation of the intestinal mucosa
is required [5], whereas others demonstrated the importance of
postabsorptive effects by injecting nutrients intravenously [6,7].
More recently it has also been suggested that, independently of
taste, tissue glucose utilization is necessary for glucose consump-
tion to cause dopamine release in the striatum [8]. In any case, the
postingestive signaling pathways leading to behavioral condition-
ing and dopamine release remain controversial.
Here we were interested in clarifying the participation of
preabsorptive and postabsorptive mechanisms in the reward-
related effects of a calorie-containing sugar, independently of its
taste. To that effect, we used rats to test the behavioral and
dopaminergic responses to intravenous glucose administration in
the jugular vein (JV) and hepatic-portal vein (HPV). We initially
tested whether several different concentrations of glucose (5%,
22.5% and 50%), administered in the JV, were sufficient to
condition a side-bias in a two-bottle preference test. In this
experiment, saccharin was used as a control for potential
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glycemic effects of the different glucose stimuli administered in the
JV, the effects of 5% glucose administered in the HPV was tested
in the same behavioral paradigm. In that experiment, mannitol
was used as a control for osmotic effects. Subsequently, the
glycemic effects of the different glucose stimuli used in these
experiments were measured simultaneously in tail and HPV blood,
to assess the relevance of changes in each of these locations for the
behavioral effects observed previously. Finally, using cyclic
voltammetry, dopamine transient frequency was measured in the
NAcc and the effects of HPV and JV infusion of a 5% glucose
solution was tested.
Results
To clarify the participation of mucosal (intestinal) vs. postab-
sorptive mechanisms in taste-independent conditioning by post-
ingestive effects in rats, we conducted experiments to test reversal of
side-bias in a two-bottle behavioral paradigm [2]. Briefly, animals
were tested for side-bias in a two-bottle water vs. water test under
water and mild food restriction. To condition side-bias reversal,
animals were then exposed to a 4 day conditioning protocol with
free access to water given daily on alternate sides of the behavioral
box. On the 2 days when animals were exposed to the side opposite
to original bias, 3 mL glucose solution was administered simulta-
neouslyto waterconsumptionandcontingentuponlicking behavior
(3 mL/lick for the first 1000 water licks). On the remaining 2 days,
when animals were exposed to the side of original bias, vehicle was
given under the same conditions. In some animals, previously
implanted with vascular catheters, conditioning stimuli (glucose or
vehicle) were infused intravenously, while in others they were
delivered orally through an independent cannula in the sipper tube
used for water delivery (see Methods). In the final testing day, side-
bias reversal was tested in all animals using a two-bottle water vs.
water test (see Methods and Table 1 for details).
Two groups of animals were conditioned using either 5% (n=6)
or 15% (n=5) glucose solutions delivered orally. Overall, the
animals in these groups had higher consumption levels during
vehicle conditioning sessions than during glucose sessions, an effect
that could be due to the satiating effects of glucose administration or
to the use of high levels of water deprivation (Fig. S1A). Side-bias
reversal was tested by comparing preference for the side opposite to
each animal’s original bias in pre and post-conditioning two-bottle
sessions. We found significant effects for conditioning stimulus (5%
vs. 15%, F=9.3, p=0.014) and testing session (pre vs. post-
conditioning, F=7.9, p=0.021), and a close to significant
interaction between the two factors (F=4.2, p=0.071; repeated-
measures two-way ANOVA). However, significant increases in pre
vs. post-conditioning preference for the side associated to glucose
delivery was found only in animals conditioned with 15% glucose
(0.1160.06 vs. 0.860.2, t=3.3, p,0.05), but not those conditioned
with 5% glucose (0.0760.04 vs. 0.1860.15, t=0.6, p.0.05; post-
hoc Bonferroni t-tests; Fig. 1A).
Using the same behavioral protocol, we tested the effects of JV
infusions of low (5%, n=10), intermediate (22.5%, n=7) and high
(50%, n=11) glucose solutions. Sodium saccharin (NaSacc;
3.16%, shown previously to be the optimal concentration for
intravascular stimulation of sweet taste [9]) was used as a control
for potential intravascular taste stimulation (n=5). Similarly to
what was found in animals conditioned orally, overall these rats
had higher consumption levels during vehicle conditioning sessions
than during glucose or saccharin sessions (Fig. S1B). Regarding
side-bias reversal, we found significant effects for conditioning
stimulus (low vs. intermediate vs. high glucose vs. NaSacc, F=7.8,
p,0.001), testing session (pre vs. post-conditioning, F=45.3,
p,0.001) and the interaction between these factors (F=15.8,
p,0.001; repeated-measures two-way ANOVA). Side-bias rever-
sal was found in animals conditioned with JV infusions of 22.5%
(0.1860.05 vs. 0.6360.10, t=4.7, p,0.001) and 50% glucose
(0.1360.05 vs. 0.8260.07, t=9.1, p,0.001), but not those
conditioned with 5% glucose (0.1460.05 vs. 0.1260.05, t=0.3,
p.0.05) or NaSacc (0.1960.09 vs. 0.360.19, t=1, p.0.05; post-
hoc Bonferroni t-tests; Fig. 1B). In summary, while the two higher
concentration glucose solutions resulted in side-bias reversal, no
effect was found for NaSacc, thus eliminating intravascular taste as
the cue for these behavioral changes.
To better understand the glycemic impact of the different
glucose stimuli, separate groups of animals were allowed free
access to water in 10 minute-long behavioral sessions while 3 mL
of each of the glucose solutions used for conditioning were
administered simultaneously to water consumption and contingent
upon licking (3 mL/lick for the first 1000 water licks; 5% oral,
n=3; 15% oral, n=4; 5% JV, n=6; 22.5% JV, n=4; 50% JV,
n=6). Glycemia was measured from tail blood before (baseline)
and at several time-points after glucose administration (09–409).
With the exception of oral 5% glucose, all stimuli caused a
significant increase of peripheral glycemia (Fig. 2A, see Table S1
for data). This effect was also verified for JV 5% glucose, which did
not condition side-bias reversal, showing that elevation of
peripheral glycemia is insufficient to induce side bias changes.
To further clarify the glycemic profile of each stimulus, both
absolute (mg/dL) and relative measures (% baseline) of glycemia
were analyzed in terms of mean and peak glycemia. In animals in
which glucose was administered orally, no differences were found
for peak relative glycemia (% baseline) after exposure to 5% and
15% glucose (11768 vs. 13169, respectively, t=1.1, p=0.33,
Table 1. Methods for Conditioning to Postingestive Effects.
Oral Stimulus Conditioning Stimulus
Bias Side Other Side (intravenous or oral)
Day 1 Pre-conditioning test Two-bottle Water Water -
Day 2 Conditioning session 1 One-bottle - Water Glucose or other
Day 3 Conditioning session 2 One-bottle Water - Vehicle
Day 4 Conditioning session 3 One-bottle - Water Glucose or other
Day 5 Conditioning session 4 One-bottle Water - Vehicle
Day 6 Post-conditioning test Two-bottle Water Water -
doi:10.1371/journal.pone.0024992.t001
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which was effective in conditioning side-bias reversal, was
compared to those resulting from JV administration of glucose, a
significant main effect was found (F=37.7, p,0.0001, one-way
ANOVA). Pair-wise comparisons revealed differences relative to
JV 22.5% (428634, t=5.8, p,0.001) and 50% glucose (536648,
t=8.6, p,0.001), but not relative to 5% glucose (170610, t=0.8,
p.0.05; post-hoc Bonferroni t-tests; Fig. 2C). Similar results were
found for peak and mean absolute glycemia (Figs. S2A, B, D and
E) and mean relative glycemia (Figs. S3A and B).
Our findings suggest that, while intravenous glucose was
sufficient to condition side-bias reversal in a two-bottle water vs.
water test, this was only possible when glycemia levels much higher
than those resulting from oral glucose were induced. We thus
hypothesized that systemic hyperglycemia from JV glucose
administration was necessary to drive a peripheral sensor that is
activated following gastrointestinal glucose administration. The
HPV system has an optimal location for such a sensor, since it
carries most nutrient-rich blood from the gastrointestinal system,
before it is released into the systemic circulation. To test this
hypothesis, the same conditioning protocol was performed with
5% glucose administered through HPV catheters (n=10), rather
than orally or through the JV. As an osmotic control, another
(sweet tasting) monosaccharide (5% mannitol [10]) was applied as
a conditioning stimulus in an alternate group of animals (n=5 Fig.
S1C). In this experiment no differences in consumption were
found during vehicle vs. glucose or mannitol conditioning sessions.
Rather, animals conditioned with glucose had overall higher
consumption levels than those conditioned with mannitol (Fig.
S1C). When considering the behavioral effects in other condition-
ing sessions (Figs. S1A and S1B) this suggests that, under these
conditions, mannitol produced a contextual aversive effect that
generalized to vehicle sessions. Regarding side-bias reversal,
significant effects were found for conditioning stimulus (glucose
vs. mannitol, F=10.2, p=0.007), testing session (pre vs. post-
conditioning, F=5.2, p=0.04) and the interaction between these
factors (F=9.5, p=0.009; repeated-measures two-way ANOVA).
Furthermore, in support of our hypothesis, a significant increase
was found in pre vs. post-conditioning preference for the side
associated with glucose (0.1760.05 vs. 0.6960.12, t=4.7,
p,0.001), but not mannitol infusion during conditioning
(0.1460.04 vs. 0.0660.06, t=0.5, p.0.05; post-hoc Bonferroni
t-tests, Fig. 3A). Thus, 5% glucose was effective in conditioning
side-bias reversal when administered in the HPV (Fig. 3A), but not
the JV (Fig. 1B). This variation in the behavioral effects of 5%
glucose did not result from differences in systemic glycemia
depending on the administration site, since peak tail blood
glycemia (% baseline) after HPV (171613) and JV administration
(Fig. 1D) were not significantly different (t=0.07, p=0.9,
unpaired t-test; Fig. 3B; see table S1 for data). Differences were
also not found for peak and mean absolute glycemia (Figs. S2C
and F) and mean relative glycemia (Fig. S3D).
Overall, these findings strongly indicate that an increase in HPV
glycemia, rather than systemic glycemia, is a critical stimulus that
results in taste-independent side-bias reversal. To further test this
hypothesis, separate groups of anesthetized animals were injected
with vehicle or the different glucose solutions used for condition-
ing, via catheters inserted into the duodenum (water, n=5; 5%
glucose, n=4; 15% glucose, n=6), JV (saline, n=5; 5% glucose,
n=6; 22.5% glucose, n=4; 50% glucose, n=4) or HPV (saline,
n=4; 5% glucose, n=7). Glycemia was measured from both tail
and HPV blood at the start (baseline) and end (09) of the stimulus
perfusion, and every 10 minutes thereafter (109–509). Raw data
were analyzed separately for vehicle and glucose injections and for
tail and HPV blood glycemia (Fig. 4, see Table S2 for data). As is
explained for glycemia in awake animals, peak and mean glycemia
Figure 1. Jugular vein administration of glucose is sufficient to condition side-bias reversal. A. In animals conditioned with 15%, but not
5% glucose, delivered orally, there was a statistically significant reversal of original side-bias. B. In animals conditioned with stimuli administered in
the JV, only those exposed to 22.5% and 50% glucose, but not 5% glucose or 3.16% NaSacc (to control for intravascular taste), reversed side-bias after
conditioning. *p,0.05, **p,0.001, ***p,0.0001.
doi:10.1371/journal.pone.0024992.g001
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peak relative glycemia (% of baseline), a significant interaction was
found between stimulus (JV vs. HPV vs. duodenal 5% glucose vs.
duodenal 15% glucose vs. JV 22.5% glucose vs. JV 50% glucose
vs. vehicle) and blood sampling site (tail vs. HPV; F=11.4,
p,0.001), allowing for separate analyses of tail and HPV glycemia
(see Table S4 for details). In either case, glycemia after JV 5%
glucose, considered as a control stimulus that did not condition
side-bias reversal (see Fig. 1B), was compared to that observed
after the remaining stimuli. For tail blood measurements, only JV
22.5% and 50% glucose and vehicle, but not HPV 5% and
duodenal 5% and 15% glucose, differed significantly from JV 5%
glucose (Fig. 4C). For HPV blood measurements however,
duodenal 5% glucose, the only other glucose stimulus that did
Figure 2. Jugular vein infusion of glucose stimuli that condition side-bias reversal also lead to extreme tail-blood hyperglycemia. A.
In awake animals, glycemia (mg/dL) was measured from tail blood at the start (baseline), end (09) and at 10 minute intervals after (109–409) behavioral
sessions where one of the glucose solutions used for conditioning was administered. Significant overall effects were found for stimulus (5% vs. 22.5%
vs. 50% JV glucose vs. 5% vs. 15% oral glucose; F=25.5, p,0.0001), time (baseline vs. 09 vs. 109 vs. 209 vs. 309 vs. 409; F=38, p,0.0001) and the
interaction between these factors (F=12.6, p,0.0001; repeated-measures two-way ANOVA). Given this interaction, data was analyzed separately for
each stimulus, showing a significant effect for time in all cases (JV 5% glucose, F=14.5, p,0.0001; JV 22.5% glucose, F=20, p,0.0001; JV 50%
glucose, F=28, p,0.0001; oral 15% glucose, F=3.2, p=0.036) with the exception of oral 5% glucose (F=2.7, p=0.087; repeated-measures one-way
ANOVA). Furthermore, when glycemia at each time-point was compared to the respective baseline measure, significant effects were found at several
time-points for JV 5% glucose (09 and 109), JV 22.5% glucose (09,1 0 9,2 0 9 and 309), JV 50% glucose (09,1 0 9,2 0 9,3 0 9, and 409), oral 15% glucose (109,
209 and 309), but not for 5% oral glucose (post-hoc Bonferroni t-tests, see Table S1 for details). B–C. Peak relative glycemia (% of baseline) was
compared after administration of glucose stimuli previously shown to be effective to condition side-bias reversal (hatched bars) and others that failed
to do so (gray bars). We did not find significant differences between animals that consumed 5% or 15% glucose orally (B). Furthermore, glycemia after
oral delivery of 15% glucose was significantly lower relative to that found after other stimuli that induced side-bias reversal (22.5% and 50%), but did
not differ relative to 5% glucose, that did not condition such reversal (C). *p,0.05, ***p,0.0001.
doi:10.1371/journal.pone.0024992.g002
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stimulus that did not differ significantly from JV 5% glucose
(Fig. 4D). Thus, in accordance with our prior findings, HPV, but
not systemic glycemia, as measured in anesthetized rats, accurately
reflects side-bias reversal observed after conditioning in awake
animals. This similarity between behavioral effects and HPV peak
glycemic response was not found for mean glycemia (Table S4),
suggesting that the relevant behavioral effects of glucose
administration result from episodic high levels of glycemia rather
than the effects of sustained glycemia changes. Similar results were
found when absolute levels of glycemia (mg/dL) were compared
(Table S3).
Prior studies have demonstrated that dopamine release can be
evoked in the nucleus accumbens, in response to gastrointestinal
delivery of sugars, independent of their taste [2,4,11]. We were
therefore interested in understanding if dopamine release in this
area would be differentially affected by JV vs. HPV administration
of 5% glucose. Fast-scan cyclic voltammetry was used to identify
spontaneous dopamine release events or ‘‘transients’’
[12,13,14,15] in the nucleus accumbens shell of anesthetized rats
(n=12) (see methods). After obtaining baseline recordings for 6 to
8 minutes, rats were infused in the JV vein with 5% glucose or in
the HPV with either 5% glucose or vehicle. The baseline transient
frequency (3.460.7 transients/min), duration (520668 msec) and
amplitude (3063 nM) were similar to what has been described in
awake animals [12,14,15] (see Figs. 5A and B for representative
recordings). Furthermore, once glucose induced changes were
measured, cocaine (15 mg/kg) was administered to all animals to
show the effects of dopamine reuptake inhibition under these
conditions. We found that cocaine increased transient frequency
and duration, without affecting amplitude (Fig. S5).
With regard to the changes in transient frequency after glucose
administration, repeated-measures two-way ANOVA revealed a
significant main effect for time (baseline vs. 1–5 min vs. 6–10 min
vs. 11–15 min vs. 16–20 min; F=2.7, p=0.044) but not for
treatment group (JV glucose vs. HPV glucose vs. HPV saline;
F=1.6, p=0.26), and a significant interaction between factors
(F=2.4, p=0.036, Fig. 5C). Given the significant interaction
between factors, further comparisons for the effect of time were
performed separately for each treatment group. For HPV saline
and JV glucose groups, the effect of time was not significant
(F=0.5, p=0.75 and F=0.61, p=0.66 respectively) and com-
parison at each time period relative to the respective baseline was
also not significant (t,1.1 and t,1.5 respectively, p.0.05 for all).
However, for the HPV glucose group, a significant effect of time
was found (F=3.9, p=0.031; repeated-measures one-way AN-
OVA) and, when compared to baseline, the transient frequency
was higher for the first 5 minutes after infusion onset (t=3,
p,0.05) but not in the remaining time periods (t,1.7, p.0.05 for
all; post-hoc Bonferroni t-tests; see Table S5 for details). No effects
were found for time, treatment group or their interaction with
respect to transient duration or amplitude (Fig. S4). In these
animals, tail blood glycemia was also determined before and
20 minutes after onset of JV or HPV infusions, showing, as
expected, that the observed differences in transient frequency after
glucose infusion are not due to differences in systemic glycemia
(Fig. 5D). Thus, in accordance with the presented behavioral and
glycemia data, at a lower concentration (5%), glucose significantly
increased dopamine transient frequency when infused into the
HPV, but not the JV.
Discussion
In this study we demonstrate that postabsorptive mechanisms
participate in the behavioral and dopaminergic reward-related
effects of glucose, independently of the hedonically positive aspects
of its taste. We first found that, in rats, high concentration glucose
solutions administered in the JV were sufficient to condition a side-
bias (Fig. 1B). However, this was only possible at glucose
concentrations resulting in much higher glycemia than that
Figure 3. Hepatic-portal vein administration of glucose conditions side-bias reversal at lower concentrations than those needed
with jugular vein administration. A. In animals conditioned with 5% glucose, but not 5% mannitol, administered in the HPV, we found a
significant reversal of original side-bias. B. In awake animals, peak tail blood glycemia (% of baseline) after HPV 5% glucose, that conditioned side-bias
reversal (hatched bar), was not significantly different from that observed after JV administration of 5% glucose, that failed to condition these
behavioral effects (gray bar). ***p,0.0001.
doi:10.1371/journal.pone.0024992.g003
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were also sufficient to condition side-biases (Fig. 2). To clarify this
inconsistency, further experiments were conducted to compare the
effects of glucose administered in the JV and HPV, since the latter
is the first site of glucose accumulation after absorption in the gut
[16]. In this regard, we found that, at a lower concentration,
glucose solutions conditioned robust side-biases when adminis-
tered in the HPV, but not the JV (Fig. 3A). In support of this
finding, enteric administration of glucose at a concentration that is
sufficient to elicit behavioral conditioning (Fig. 1A) resulted in a
glycemic profile similar to that observed after administration of the
low concentration glucose solution in the HPV, but not the JV
(Fig. 4). Finally, the administration of a low concentration glucose
solution in the HPV, but not the JV, caused an increase in the
frequency of dopamine transients in the nucleus accumbens shell,
as measured by fast-scan cyclic voltammetry (Fig. 5). Overall, these
findings support that the postabsorptive effects of glucose are
sufficient for the postingestive behavioral and dopaminergic
reward-related responses resulting from sugar consumption, and
glycemia levels in the HPV system contribute more significantly to
this effect than systemic glycemia.
The differential participation of oral and postingestive factors in
the control of feeding behavior have been well characterized [1].
The postingestive controls of food intake were mostly recognized
as inhibitory influences (i.e., satiation) but less research was
dedicated to the positive postingestive effects of food intake [17].
While several early authors demonstrated that intragastric
injection of nutrients can serve as an adequate behavioral
reinforcer [18,19], this finding was controversial and attributed
to leaks in the gastric cannulation system [1,20]. In fact, most
authors developed work showing that nutrients injected directly
into the stomach will condition a preference for an associated
flavor [20,21,22,23,24,25], and only recently did we find that, in
mice without functional sweet-taste transduction in taste receptor
cells, oral consumption of sucrose was sufficient for the
conditioning of robust side-preferences, independently of any oral
cues [2]. Here, the behavioral procedure developed previously in
mice [2] was adapted for use in the rat, and we demonstrated that
Figure 4. Increases in hepatic-portal vein blood glycemia parallel the capability of glucose stimuli to condition side-bias reversal.
Tail and HPV blood glycemia was measured in anesthetized rats at the start (baseline) and several time-points after (09–509) perfusion of vehicle
(duodenal water, JV saline or HPV saline) or one of the different glucose solutions used for conditioning (duodenal 5% or 15% glucose, JV 5%, 22.5%
or 50% glucose or HPV 5% glucose). A. For tail blood glycemia, measurements after glucose injections, a significant overall effect was found for time,
stimulus and the interaction between these factors (p,0.0001 for all; repeated-measures two-way ANOVA). Further comparisons were performed
relative to JV 5% glucose, considered as a control stimulus that did not condition side-bias reversal, revealing several time-points after JV 22.5% and
50% and duodenal 15% glucose where glycemia was significantly elevated (see Table S2 for details). B. In terms of HPV blood glycemia,
measurements after glucose injections, a significant overall effect was found for time, stimulus and their interaction (p,0.0001 for all; repeated-
measures two-way ANOVA). Again, significant elevations of glycemia where found at several time-points after JV 22.5% and 50% and duodenal 15%
glucose, when compared to those verified after JV 5% glucose (see Table S2 for details). C–D. Peak relative glycemia (% of baseline) was also
compared after administration of vehicle (black bars), glucose stimuli previously shown to be effective to condition side-bias reversal (hatched bars)
and others that failed to do so (gray bars). Peak glycemia for each stimulus was again compared to that after to JV 5% glucose, considered as a
control stimulus that did not condition side-bias reversal and differences were parallel to the behavioral effects of each stimulus for HPV (D) but not
tail (C) blood measurements. **p,0.001, ***p,0.0001.
doi:10.1371/journal.pone.0024992.g004
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PLoS ONE | www.plosone.org 6 September 2011 | Volume 6 | Issue 9 | e24992Figure 5. Nucleus accumbens dopamine transient frequency increases after injection of glucose in the hepatic-portal vein. Fast-scan
cyclic voltammetry was used to identify spontaneous dopamine release events (transients) in the nucleus accumbens shell of anesthetized rats.
Measurements were conducted for a baseline period, and also during and after infusion of 5% glucose in the JV (n=4) or HPV (n=4), or vehicle in the
latter (n=4). A. This panel shows example measurements in one animal before (figures on the left) and after (figures on the right) onset of 5%
glucose infusion in the HPV. The two dimensional color plots at the bottom of the panel show the voltammetric current (encoded in color, nA)
plotted against the applied potential on the Y axis (V) and the acquisition time on the X axis (sec.). The green spots at 0.62 V (the peak oxidation
potential for dopamine) in the lower half of the plots represent dopamine oxidation at the surface of the carbon-fiber microelectrode. The current at
the peak dopamine oxidation potentials was converted to dopamine concentration following post-calibration (see Methods) and is displayed above
the color plots, approximately aligned with them in time. The panels near the top of the figure are cyclic voltammograms of the peaks indicated by
arrows that were obtained by subtracting baseline voltammograms just prior to onset of the transient. Dopamine transients were considered as such
when they had voltammograms that were significantly correlated (r.0.86) with those of a dopamine template elicited previously by electrical
stimulation of the ventral tegmental area. The peaks that were thus classified as dopamine are indicated by asterisks. B. This panel shows an example
measurement as was described above (A) but for JV, rather than HPV administration of 5% glucose. Note that the evoked activity is much less. C.
Here we show dopamine transient frequency prior to infusion in each of the three groups (baseline) and in 5 min bins following infusion onset. Data
were analyzed using two-way repeated measures ANOVA (see text) and post-hoc analysis indicated that, when compared to the respective time
period for HPV vehicle administration, transient frequency in the HPV glucose group was significantly higher in the first 5 minutes after infusion onset
(t=3.1, p,0.05) but not in the remaining time periods (t,1.9, p.0.05 for all), or at any point in the JV glucose group (t,1.1, p.0.05 for all; post-hoc
Bonferroni t-tests). D. In the same rats, tail blood glycemia was also measured prior to and 20 minutes after infusion of 5% glucose in the JV (n=3) or
HPV (n=3), or vehicle in the latter (n=4). No differences for absolute glycemia (mg/dL) were found between groups at baseline (PV vehicle - 15767,
JV 5% glucose - 169622, HPV 5% glucose - 135614; F=1.4, p=0.31, repeated-measures one-way ANOVA; t,1.7, p.0.05 for all pair-wise
comparisons, post-hoc Bonferroni t-tests; data not shown in figure). However, as expected, an overall significant difference was found for relative
glycemia (% baseline) at 209 (F=14.6, p=0.0032, repeated-measures one-way ANOVA), with significant differences between glycemia after HPV
vehicle (9364) and that after JV 5% glucose (12966; t=3.5, p,0.05) and HPV 5% glucose (147612; t=5.2, p,0.01). Importantly, no differences were
found between values after each of the two glucose stimuli (t=1.6, p.0.05, post-hoc Bonferroni t-tests). *p,0.05, **p,0.001.
doi:10.1371/journal.pone.0024992.g005
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enteric consumption of glucose (Fig. 1A).
While the literature on positive postingestive controls of food
intake is now almost 60 years-old, the peripheral signals
underlying these effects, particularly those of glucose, remain
controversial [5]. Experiments with parenteral administration of
glucose solutions in rats or rabbits, to test its effects as a signal for
positive postingestive conditioning, have had both positive
[7,26,27,28,29] and negative results [30,31,32]. Here we have
demonstrated a dose-response effect in the capability of glucose to
condition behavior, when administered in the JV (Fig. 1B). These
results provide a reasonable explanation for prior discrepancies
with JV glucose administration, since positive findings had been
obtained with higher concentrations of glucose (30%) [7] than
those used in experiments with negative results (10%) [31,32].
In rats, the HPV was previously proposed as an important site
for the detection of postabsorptive signals which support appetitive
postingestive conditioning [6]. In a later study conducted in food
deprived rats, HPV glucose injections were not found to condition
flavor preferences, leading to the proposal that intestinal
stimulation by nutrients is necessary for HPV infusions to
condition behavior [5]. Here we find that, even in food deprived
rats, HPV glucose infusion was sufficient to condition a side bias
(Fig. 3A). When compared to the above noted negative
experiments [5], these results cannot be explained by the use of
higher glucose concentrations (5% used here vs. their 10%), but
may be a consequence of differences in the rate of infusion (no less
than 0.3 mL/min here vs. 0.083 mL/min). Furthermore, in
accordance with previous findings [6], infusion of the same
concentration of glucose in the JV had no such effects (Fig. 1B).
Thus, while our data cannot exclude the importance of intestinal
nutrient stimulation for appetitive postingestive conditioning, they
clearly show that it is not necessary, and that postabsorptive
factors, acting peripherally in the HPV system, are sufficient for
such behavioral effects.
It is important to note that glucose and other nutrients present
in the gut will be absorbed, resulting in a greater increase in blood
nutrient levels in the HPV than in the systemic circulation [16].
This effect will presumably be additive to that of nutrient injection
into the HPV, presenting a reasonable explanation for the
previously noted association between the presence of nutrients in
the intestine and the capacity of HPV infusions to condition
behavior [5,6]. Thus, when comparing the behavioral effects of
enteric, JV and/or HPV nutrient infusions, it is important to
directly measure blood nutrient levels resulting from these
infusions. However, only a few of the studies investigating the
positive conditioning effects of intravenous glucose administration
have included systemic blood glycemia measurements, with mixed
results [27,31,33], and none included these measurements in HPV
blood. Here we show, both in awake and anesthetized rats, that
tail blood glycemia measurements did not entirely explain the
differential behavioral effects of enteric, JV and HPV glucose
infusions (Figs. 2, 3B, 4A, 4C, S2 and S3; Tables S1, S2, S3 and
S4). However, when measurements were performed in the HPV
blood of anesthetized animals, peak glycemia was found to be a
good correlate of the capacity of glucose solutions to condition
side-biases (Figs. 4B and 4D; Tables S2, S3 and S4). This was not
true for mean glycemia, reflecting the fact that intravenous
injection of glucose did not result in an entirely physiological
glycemic profile, and also suggesting that the observed behavioral
effects of glucose administration were more dependent on the
highest levels of glycemia than on sustained glycemia elevations. In
any case, these findings further support the importance of
postabsorptive glucose load in the HPV for appetitive postingestive
conditioning showing, importantly, that this is true even when
nutrients are administered in the gut, rather than directly in the JV
or HPV.
Experiments performed to investigate the negative (i.e.,
satiating) effects of nutrients injected into the HPV have also
been performed in several species. As described for positive
conditioning, inconsistent results have been noted, (see [6,34] for
reviews). The reason for these differences has been variously
attributed to the animal’s nutritional status, the protocol for HPV
infusion and the different testing paradigms [34]. In fact, most of
these factors will presumably impact the nutrient level in the HPV,
suggesting that this factor could underlie the satiating effects of
intravenous nutrient infusions, as is described here for positive
behavioral conditioning.
In the behavioral experiments with glucose infusions in the JV
or HPV, control solutions were also used, to differentiate between
effects due to the nutritional character of glucose, from those that
could result from taste stimulation or changes in osmolality. For JV
infusion experiments, a sodium saccharin solution was used, at a
concentration that was previously shown to be optimal for
intravascular stimulation of sweet taste [9]. For HPV infusions,
mannitol was used since, at equal concentrations to glucose, this
sweet-tasting monosaccharide causes similar changes in plasma
osmolality, but has minimal metabolic effects [10]. Contrary to
glucose, both saccharin and mannitol did not condition side-bias
changes after infusion into the JV or HPV respectively, eliminating
taste and plasma osmolality as the mechanism underlying those
behavioral effects (Figs. 1B and 3A). These important controls
supported our prior findings of taste-independent behavioral
conditioning with sucrose in mice [2], and also the early reports of
instrumental and place preference conditioning resulting from
intragastric and intravenous administration of nutrients, in the
absence of orosensory or olfactory cues [18,19,26,27].
The role of dopamine in mediating the appetitive characteristics
of food has previously been well established [35]. Elevation of
dopamine levels in the nucleus accumbens (NAcc) occurs upon
consumption of calorie-containing sugars such as sucrose [36,37],
and both sweet taste and postingestive stimulation have been
shown to be sufficient for this effect [2,38,39]. However, the
postingestive mechanisms leading to dopamine release in the NAcc
after consumption of sugars, remain unclear. Arguing for the
importance of preabsorptive stimulation, the gut-derived hormone
ghrelin has been shown to stimulate mesoaccumbens dopamine
release [40]. Evidence for postabsorptive controls of striatal
dopamine release has also been presented, but the reported
findings are somewhat equivocal [8,41,42]. Importantly, the effects
of glycemia on striatal dopamine homeostasis has been attributed
to glucosensing neurons in the brain [41], in particular since
increases in dorsal striatum dopamine levels have been found to
occur when glucose is infused directly in the substantia nigra [43].
Here, using cyclic voltammetry, we found that 5% glucose infused
in the HPV, but not the JV, resulted in an increase of dopamine
transient events (Figs. 5A–C), while causing a similar and
physiologically relevant increase in peripheral glycemia in both
cases (Figs. 3B, 4A, 4C and 5D). This finding confirms that
postabsorptive glucose signals are sufficient to elicit dopamine
release in the NAcc, also demonstrating, to our knowledge for the
first time, that these postabsorptive effects are dependent on the
increase of glycemia in the HPV, rather than from direct detection
in the brain or alternate mechanisms, such as intravascular taste.
The differential dopaminergic effects of 5% glucose administered
in the JV and HPV are particularly relevant given that they are
parallel to the differential effects of these treatments on behavior
(Figs. 1B and 3A) and HPV glycemia (Figs. 4B and 4D), suggesting
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behavioral and neurochemical effects of glucose administration.
Although spontaneous dopamine transients have been reported
in awake rats [44,45], we note that, to our knowledge, this is the
first report in anesthetized rats (Fig. 5A and 5B). Nevertheless, we
found that all three characteristics used to describe transients
(frequency, duration and amplitude) are quite similar to those
reported in awake rats [14,15,44,46,47]. Furthermore, even in
anesthetized rats, transient frequency was responsive to both
glucose infusion into the HPV (Fig. 5C) and to i.p. administration
of cocaine (Fig. S5A). Prior experiments using cyclic voltammetry
had described NAcc dopaminergic responses to intra-oral sucrose
[47] or saccharin [39] infusion. In comparison with these previous
voltammetric studies, we report sustained increases in transient
frequency over a period of minutes after intravenous glucose
infusion, rather than the responses over a few seconds which occur
after oral stimulus presentation [46,48]. Similarly to what has been
previously described for nomifensine [15] and cocaine [45]
administration, we also found that injection of 15 mg/kg cocaine
caused an increase of NAcc dopamine transient frequency (Fig.
S5A) and duration (Fig. S5B). However, we found no effects for
transient amplitude (Fig. S5C). Thus, the effects of psychostimu-
lants are similar in awake and anesthetized rats. Investigating
effects on transients in anesthetized rodents may be most
appropriate in contexts in which environment and conditioning
are unwanted confounds.
The NAcc, where we measured dopamine transients, is not a
homogenous structure. There are two main subdivisions, the Nacc
core and Nacc shell, for which functional differences in reward
processing and dopamine release kinetics have been reported
[49,50]. The voltammetry data reported here was measured with
electrodes implanted in the shell subregion. In fact, the effects we
observed after cocaine injection (Fig. S5A) are in accordance with
previous findings, showing that cocaine increases transient
frequency in this subregion, but not the NAcc core [51].
Dopamine transmission within the NAcc shell has been proposed
to participate in primary reward processing in response to both
psychostimulants [49,51] and oral ingestive stimuli [39], while the
release of dopamine in the NAcc core is thought to have a more
specific role in the response to reward predicting cues in the
context of learned associations [39,49]. We now show that HPV
glucose infusion causes an increase of dopamine transient
frequency in the NAcc shell, an effect that, as suggested from
the effects of dopamine receptor antagonism in the same area,
could be relevant for flavor preference learning induced by the
post-oral consequences of carbohydrates [4]. In any case, further
research is needed to explore the participation of the NAcc core in
the postabsorptive responses to sugars.
Prior research had suggested that sweet-detection and trans-
duction mechanisms that are found on taste cells on the tongue,
are also present in the gut, and are a critical postingestive regulator
of the appetite for sugars [52]. However, we and others have
shown that non-nutritive sweeteners, that will also activate these
mechanisms [52], do not condition side [2] or flavor [53]
preferences. Furthermore, even though taste-like detection and
transduction mechanisms are defective, both Trpm5 KO [2] and
T1R3 KO [53] mice will develop preferences conditioned by
nutritive sugars. The results described here support that a
postabsorptive factor, dependent on glycemic changes in the
HPV, rather than systemically, contributes to the positive
behavioral effects and the NAcc dopaminergic effects resulting
from the consumption of sugars. While these results argue against
a major role for the participation of a preabsorptive mechanism,
such a mechanism cannot be excluded and, in fact, there is
evidence that mucosal and postabsorptive factors could cooperate
in postingestive conditioning [5]. In any case, the nature of
glucose-dependent HPV postabsorptive factors is still to be
determined. One possibility is the participation of insulin,
particularly since this hormone was shown to be relevant for the
dopaminergic response to hyperglycemia [41]. Another candidate
intervening mechanism is net hepatic glucose uptake, since it is
dependent on insulin levels [54] and is increased when glucose is
delivered in the HPV, in comparison to peripheral infusion [55]. A
relationship between liver energy status, measured in terms of
hepatocyte ATP concentration, and food intake has also been
shown [56]. Ultimately, these factors could also explain recent
findings, showing that glucose utilization is necessary for the
behavioral conditioning and dopaminergic effects of glucose
consumption [8]. The mechanism for transmission of signals from
the liver to the brain is also unclear. One hypothesis is neural
transmission, possibly via glucose-sensitive vagal afferent neurons
[57]. However, lesioning abdominal vagal and non-vagal neural
afferents has not been shown to block flavor preferences
conditioned by enteral administration of glucose polymers
[58,59,60]. Another alternative, which has been less explored
[61], is that humoral factors, possibly produced by the liver and/or
pancreas, are released in the bloodstream and act directly in the
brain to modulate food intake [62].
In summary, these findings support the claim that the
postabsorptive effects of glucose are sufficient to induce appetitive
behavioral responses towards sugar consumption, and that
glycemia levels in the HPV system contribute more significantly
for this effect than systemic glycemia. Moreover, these effects
occur independently of taste, postingestive mucosal stimulation,
and plasma osmolality. Furthermore, this is the first demonstra-
tion, that HPV glucose administration is sufficient to induce
striatal dopamine transients, an effect that could underlie the
positive behavioral effects of this treatment. Given the dramatic
behavioral effects of gastrointestinal bypass surgery for weight
reduction [63,64], with potential effects on HPV nutrient levels,
we believe that the mechanisms described here could play a part in
the etiology and treatment of human obesity, thus meriting further
and more extensive research in both animal and human models.
Materials and Methods
Ethics Statement
All procedures were carried out in strict accordance with
protocols approved by the Duke University Institutional Animal
Care and Use Committee (protocol number A329-07-12).
Subjects
One-hundred forty-four male Long-Evans rats and 12 male
Sprague-Dawley rats were obtained from Charles Rivers Labora-
tories (Raleigh, NC) and housed individually in Plexiglas cages. All
animals were maintained on a 12 hr light/dark schedule and
experiments were carried out in the light portion of the cycle. At
the time of each experiment, animals were 3 to 6 months old and
naı ¨ve for the stimuli used. Preliminary experiments demonstrated
that, under the conditions necessary to conduct experiments with
intravenous injections, stable licking rates could be obtained only
when oral access to water was restricted to behavioral sessions.
Thus, Purina rodent chow and water was available ad libitum,
except for the duration of behavioral testing, when animals were
food deprived overnight and had access to water only during the
behavioral task. In experiments conducted in anesthetized
animals, they were food and water restricted approximately
24 hours prior to the experiment. In those animals whose body
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was discontinued and the animals were excluded from the
experiment.
Stimuli
All infused solutions (D-glucose – 5%, 15%, 22.5% and 50%; D-
mannitol – 5%; sodium saccharin – 3.16%) were prepared daily in
deionized water or 0.9% NaCl and maintained at room
temperature. Deionized water and 0.9% NaCl solution were also
used and are designated as ‘vehicle’. Deionized water was also
delivered orally, as were, in another set of experiments, 5% and
15% glucose solutions prepared in deionized water. D-glucose, D-
mannitol, sodium saccharin, deionized water and NaCl are
referred to in the paper as glucose, mannitol, saccharin, water
and saline respectively. All chemicals were obtained from Sigma-
Aldrich (St. Louis, MO) and were reagent-grade.
Jugular and Hepatic Portal Vein (HPV) Catheterization
Polyurethane catheters (Strategic Applications, Inc., Liberty-
ville, IL), were implanted in the right jugular vein in 75 rats and in
the hepatic portal vein in 35 rats. Some animals were catheterized
offsite (Charles Rivers Laboratories, Wilmington, MA) while
others were catheterized in-house using the same procedure.
Briefly, animals were anesthetized using 5% halothane followed by
intraperitoneal or intramuscular injection of xylazine (5–20 mg/
kg) and ketamine (75–100 mg/kg). Supplemental doses were
administered whenever necessary. For jugular catheterization, a
small incision was performed to expose the right jugular vein. The
cranial end of the vein was ligated and a loose ligature was placed
caudally to isolate a 5 mm section of the vessel. For portal
catheterization, an abdominal midline incision was made, the
cecum was pulled out and the mesenteric vein was identified.
Similarly, the distal end of the vein was ligated and a loose ligature
was placed proximally to isolate a section of the vessel. In either
case, a catheter was inserted into an incision made between
ligatures and secured in place by tying the loose ligature around
the catheterized vessel. A small incision was then made in the
scapular region and the catheter was subcutaneously tunneled and
exteriorized through this incision. Patency was tested and the
catheter was filled with a ‘locking solution’ (500 IU/mL heparin in
50% glucose) and sealed with a plug. A subcutaneous skin pocket
was made cranially and the excess length of catheter was inserted
into the pocket. Finally, the vessel incision site and scapular area
skin incision were closed with wound clips. Animals were allowed
to recover for 3 to 5 days after surgery before initiation of further
experimental procedures. Before these procedures, the catheter
locking solution was replaced by 50 IU/mL heparin in 0.9% NaCl
solution, which was also used to maintain patency in behavioral
experiments that were conducted across several days.
Behavioral Setup
All behavioral tests were conducted in Med Associates (Med
Associates Inc., St. Albans, VT) behavior boxes, each enclosed in a
ventilated and sound-attenuating chamber, as described previously
[65]. Briefly, chambers were equipped with two slots for sipper
tubes in one of the walls. Access to sipper tubes could be blocked
by computer-controlled doors and sipper slots were equipped with
beam lickometers used for licking detection (Med Associates Inc.,
St. Albans, VT). Each sipper tube contained two 20-gauge
stainless-steel cannulae that were connected to 50-ml chromatog-
raphy columns (Kontes Flex-Columns; Fisher Scientific, Hamp-
ton, NH) where stimulus solutions were contained. The solution
containers were housed outside the sound-attenuating chambers
and kept at an elevated position to promote liquid flow by gravity.
Computer-controlled solenoids (Parker Hannifin Corporation,
Fairfield, NJ) regulated the flow of fluid such that within 10 ms
after a lick was detected, one of the valves opened and delivered
,3 mL of fluid. A syringe pump (Med Associates Inc., St. Albans,
VT) was used to allow intravascular injection of solutions during
behavioral tasks. The pump was activated 10 ms after a lick was
detected, resulting in a ,3 mL injection of whatever solution was
contained in the syringe attached to the pump. Thus, the infusion
rate was matched to licking rate (,7 Hz) and the volume of fluid
ingested was approximately equal to the amount infused.
Conditioning to Postingestive Effects
General Protocol. To test if rats develop side-biases
conditioned by glucose in a two-bottle paradigm, 72 animals
were exposed to a conditioning protocol similar to what we used
previously in mice [2]. For each animal, side-bias was determined
in a 10 minute-long test with water delivered on both sides of
the behavioral box (two-bottle water vs. water test). Once a clear
side bias was established, the animals were exposed for 4 days to
30 minute-long sessions of free access to water presented daily
on alternate sides of the box (one-bottle forced-choice training
sessions). On the first and third days, water was presented on the
side opposite to the initial side-bias and 3 mL of a conditioning
stimulus was delivered simultaneously to water for the first 1000
licks (i.e., 100063 mL=3 mL). On the second and fourth days,
water was presented on the initial side-bias and 3 mL of vehicle
(saline or water, see below for details) was delivered simultaneously
to water for the first 1000 licks. Typically, the first 1000 licks
occurred in up to 8 minutes. After training, reversal of side-bias
was tested in 10 minute-long two-bottle water vs. water tests. In
these experiments, 8 animals did not complete the conditioning
protocol due to disease or excessive weight loss and in 5 others
there was an error in the conditioning protocol. Data from these
13 animals was excluded from analysis.
Conditioning Stimuli. In 11 animals conditioning was
performed with vehicle (water) and glucose solutions (6 rats with
5% and 5 rats with 15%), delivered orally during licking for water.
In 33 animals conditioning was performed with infusions of vehicle
(water or saline – no differences were found according to vehicle
subtype, data not shown) and saccharin (5 rats) or glucose solutions
(10 rats with 5%, 7 rats with 22.5% and 11 rats with 50%)
delivered through jugular vein catheters. In 15 animals
conditioning was performed with infusions of 5% mannitol (5
rats) or 5% glucose (10 rats) delivered through portal vein
catheters. In those animals where conditioning was performed
using venous catheters, prior to both testing and conditioning
sessions, the animal was anesthetized using 5% isoflurane and the
catheter was connected to a syringe that was placed on the infusion
pump.
Blood Glucose Measurements
Awake Animals. Rats were initially trained to drink in daily
10 minute-long sessions of free access to water. Once stable
consumption levels were obtained, a test session was conducted
where, for the first 1000 water licks, a particular stimulus (,3 mL)
was delivered orally or infused, simultaneously to licking. In 7
animals glucose solutions (3 rats with 5% and 4 rats with 15%)
were delivered orally. In 20 animals glucose solutions were
delivered through jugular vein catheters (6 rats with 5%, 4 rats
with 22.5% and 6 rats with 50%) or portal vein catheters (4 rats
with 5%). On the test day, tail blood was collected for
determination of glycemia both before and immediately after
exposure to the testing chamber (respectively baseline and 09), and
also at 10 minute intervals after the animal was returned to his
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hand-held glucometer (Precision Xtra, Abbott Laboratories,
Abbott Park, IL, USA; maximal detection level of 500 mg/dL).
Anesthetized Animals. Naı ¨ve rats were anesthetized using
5% halothane followed by intramuscular injection of 50 mg/kg
pentobarbital, which has been shown to be one of the anesthetic
strategies with small effects on glycemia [66]. Supplemental doses
were administered whenever necessary. An abdominal midline
incision was made. In 15 rats, that had not received any prior
surgery, the stomach wall was punctured and a polyethylene
catheter was inserted such that its’ extremity was in the
duodenum, approximately 2 cm from the pylorus. The
remaining 30 rats had been previously implanted with jugular or
portal vein catheters. Tail blood glucose levels were measured at 5
to 10 minute intervals. Once tail blood glycemia stabilized, a
baseline glycemia measurement (09) was recorded for both tail and
portal vein blood. For collection of portal blood, the hepatic portal
vein was identified close to the hepatic hilus and a 31 gauge needle
was used to collect 0.05 to 0.1 mL of blood. 3 mL of a particular
stimulus was then injected continuously across 8 minutes using a
syringe pump (Med Associates Inc., St. Albans, VT), to emulate
conditions during behavioral training sessions. Of the animals with
duodenal catheters, 5 rats were injected with vehicle (water), 4
with 5% glucose and 6 with 15% glucose. In the 11 rats with portal
vein catheters either vehicle (saline; n=4) or 5% glucose was
administered (n=7). The remaining 19 rats had jugular vein
catheters and received either vehicle (saline; n=5) or glucose
solutions (5%, n=6; 22.5%, n=4; 50%, n=4). Tail blood and
portal vein blood were subsequently collected at 10 minute
intervals for up to 1 hour, starting 10 minutes after the initiation
of infusions (109,2 0 9,3 0 9,4 0 9,5 0 9 and 609). Glycemia in tail and
portal vein blood was measured as described above.
Fast-scan cyclic voltammetry
Electrodes. Carbon-fiber microelectrodes were prepared
from 7 mm diameter T-300 carbon fibers (Amoco, Greenville,
SC) as previously described [67]. When necessary, epoxy was
added to the glass/fiber interface to improve the seal.
Approximately 50–100 mm of fiber was left exposed past the
glass/carbon seal. All electrodes were soaked in 2-propanol with
activated Norit-A charcoal for at least 10 min before use. After
lowering to the starting depth in the nucleus accumbens,
electrodes were conditioned by cycling for 15 minutes at 60 Hz
with a triangle waveform (20.4 V to 1.3 V vs Ag/AgCl at 400 V/
sec) and then for another 15 min at the frequency used for data
collection, 10 Hz [68]. Chloridized silver wires were used as
reference electrodes and all potentials were reported vs Ag/AgCl.
Electrochemistry. For fast-scan cyclic voltammetry (FSCV)
we used a UEI electrochemical instrument (University of North
Carolina Department of Chemistry Electronics Facility, Chapel
Hill, NC). National Instruments boards (PCI-6052 and PCI-6711E)
and TH-1 software (ESA, Chelmsford, MA) were used for
waveform generation, data collection, digital filtering and
dopamine transient detection and analysis. To detect extracellular
dopamine a triangle waveform (20.4 V to 1.3 V vs Ag/AgCl at
400 V/sec) was applied to the carbon-fiber microelectrode at
10 Hz. Changes in extracellular dopamine were determined by
monitoring the current over a 100 mV window at the peak
oxidation potential for dopamine (about 0.65 V). Dopamine
currents in vivo were converted to dopamine concentrations by
calibrating the electrodes following experimental use with two
dopamine standard solutions in a flow injection system. The
composition of the buffer used for post-calibration was (in mM): 126
NaCl, 2.5 KCl, 2.4 CaCl2, 1.2 MgCl2, 2.0 Na2SO4, 1.2 NaH2PO4,
15 TRIS HCl, pH=7.4.
In-vivo Methods. Twelve rats were allowed to recover from
catheter implantation for at least 3 full days before overnight food
and water deprivation. The morning following deprivation, rats
were anesthetized with urethane (1.5 g/kg i.p.) and positioned in a
stereotaxic apparatus (David Kopf Instruments, Tujunga, CA).
Body temperature was maintained at 37uC with a Deltaphase
Isothermal Pad (Braintree Scientific, Braintree, MA). The scalp
and underlying fascia were resected and holes were drilled for
working, stimulating and reference electrodes. The stereotactic
coordinates are given in mm anteroposterior (AP) and
mediolateral (ML) from bregma, and dorsoventral (DV) from
dura. A bipolar stimulating electrode (Plastics One Inc., Roanoke,
VA) was positioned in the ventral tegmental area (VTA): 25.2 AP,
+1.0 ML, 27.5 to 29.0 DV. A carbon-fiber microelectrode was
placed in the ipsilateral nucleus accumbens shell (+1.7 AP, 0.8
ML, 26.4 to 27.4 DV). An Ag/AgCl reference wire was placed in
the contralateral cortex. Extracellular dopamine concentrations
resulting from 24 pulse 60 Hz stimulation trains (biphasic, 2 ms
each phase and 130 mA) of the VTA were recorded. The locations
of the stimulating and working electrodes were optimized to find
sites that supported electrically-stimulated dopamine release and
spontaneous dopamine transients. Dopamine templates for
subsequent transient identification were made from cyclic
voltammograms obtained from the stimulated release. All sites
selected for transient analysis supported stimulated dopamine
release with a signal to noise ratio of 30 or more. Tail blood
glycemia was determined, as described above, and baseline data
were recorded for 6 to 10 minutes without further stimulation.
Immediately after the final baseline data collection, the infusion
pump was turned on. Glucose (5% in saline) was infused (3 mL/
5 min) in either the hepatic portal or jugular vein. For the control
group, saline was infused into the portal vein. One minute files
were recorded continuously for 20 minutes, after which tail blood
glycemia was determined again and maintenance of stimulated
release was verified. Glycemia measurement could not be
performed in 2 animals, due to glucometer malfunction. To
determine if the recorded dopamine release site was responsive to
dopamine uptake inhibition, an intraperitoneal injection of
15 mg/kg cocaine was given one hour following infusion. Data
were recorded for 25 minutes following cocaine and stimulated
release was rechecked. In 4 animals, transient frequency had
degraded or was unstable at the time that cocaine was
administered.
Data Analysis
Results from data analyses were expressed as mean 6 standard
error of the mean and ‘n’ is the number of rats. Analyses were
performed with GraphPad Prism (GraphPad Software, Inc., San
Diego, California)or NCSS 2000 software (NCSS, Kaysville, UT),
and made use of two-way or one-way ANOVAs (with Bonferroni
post-hoc tests) and two-sample or one-sample t-tests. Sequential
Bonferroni correction for multiple comparisons was performed
with the Holm’s method [69] whenever multiple independent t-
tests were used in the same data set.
Behavioral Preference Measures. Two-bottle preference
tests were analyzed by calculating the preference ratios as
Preference for sipper 1~
n(Sipper1)
n(Sipper1)zn(Sipper2)
where n(.) denotes the total number of licks detected at a particular
sipper during a session. Significance tests were based on one-sample
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Blood Glycemia Measures. Baseline glycemia was defined
for each blood collection site in each animal by a single
measurement performed immediately prior to the initiation of
stimulus consumption or administration. Blood glucose levels were
analyzed as absolute values (mg/dL) or as % change with respect
to baseline. Mean glycemia after stimulus consumption or
administration was calculated and the highest glycemia value in
this period (peak glycemia) was also identified.
Dopamine Transients. Spontaneous dopamine transients
were identified using a published procedure that determined the
correspondence of putative dopamine peaks to a template
voltammogram known to be dopamine [70]. A dopamine cyclic
voltammogram that resulted from electrically-stimulated
dopamine release served as the template. Baseline cyclic
voltammograms were subtracted from those at every individual
point using an algorithm in the TH-1 software. For each data file
this analysis included four passes using baseline durations of 0.5 to
1.5 seconds that started 0.5, 1.0, 1.5 or 2.5 seconds before the
tested data point. The criteria for ascertaining dopamine transients
was taken from published methods and included two consecutive
points (0.1 second resolution) that had high correspondence with
the template (r$0.86) [14,15,70,71]. A custom-designed Matlab
program tabulated the number of transients and their durations (in
numbers of 0.1 sec points) and amplitudes by combining results
from all the passes. A transient resulted from at least two
consecutive points identified as dopamine. Amplitudes were
determined as the peak dopamine current of the transient minus
the baseline near the onset of the transient peak and converted to
dopamine concentration following the in vitro post-calibration [14].
The number of consecutive transient points (0.1 sec) was used as
transient duration [14].
Supporting Information
Figure S1 Consumption of water during conditioning
sessions. Overall consumption of water during conditioning
sessions was compared using repeated-measures two-way AN-
OVA. A. Animals conditioned with oral stimuli licked more
during vehicle than glucose administration (F=8.3, p=0.02), but
no effects were found for conditioning stimulus (5% vs. 15%
glucose, F=0.2, p=0.65) or the interaction between these factors
(F=0.05, p=0.82). This effect of reduced licking during glucose
availability was nevertheless minor, since we found no differences
in pair-wise comparisons between consumption in glucose vs.
vehicle sessions for animals conditioned with both 5% (49336117
vs. 54606141, t=2.3, p.0.05) and 15% glucose (51366259 vs.
55856502, t=1.8, p.0.05; post-hoc Bonferroni t-tests). B.
Similar to findings during oral conditioning, animals conditioned
with stimuli administered in the JV licked more during vehicle
than glucose or saccharin administration (F=4.5, p=0.04), but no
effects were found for conditioning stimulus (5% glucose vs. 22.5%
glucose vs. 50% glucose vs. 3.16% saccharin, F=1.5, p=0.23) or
the interaction between these factors (F=1.4, p=0.27). Again, no
differences were found in pair-wise comparisons between con-
sumption in glucose or saccharin vs. vehicle sessions for animals
conditioned with 5% glucose (66146356 vs. 64666334, t=0.3,
p.0.05), 22.5% glucose (50926650 vs. 61576245,
t=1.7,p.0.05), 50% glucose (48246592 vs. 60626763,
t=2.5,p.0.05) and 3.16% saccharin (48266802 vs. 52506512,
t=0.6, p.0.05; post-hoc Bonferroni t-tests). C. In animals with
hepatic-portal vein (HPV) catheters, there was overall more licking
in those conditioned with glucose relative to the mannitol group
(F=259, p,0.0001), but no effect for vehicle vs. glucose or
mannitol administration (F=0.7, p=0.41) or the interaction
between these factors (F=0.1, p=0.73). Furthermore, we found
no differences in pair-wise comparisons between consumption in
glucose vs. vehicle sessions for animals conditioned with both 5%
glucose (73146148 vs. 77586139, t=0.4, p.0.05) and 5%
mannitol (38876183 vs. 42446574, t=0.8, p.0.05; post-hoc
Bonferroni t-tests).
(TIF)
Figure S2 Mean and peak tail blood glycemia (mg/dL)
measurements in awake animals. A. In animals conditioned
orally, differences were not found for mean glycemia after 5% and
15% glucose (8467.4 vs. 9463 respectively, t=1.4, p=0.23,
unpaired t-test). B. Mean glycemia after oral 15% glucose, which
was effective in conditioning side-bias reversal, was also compared
to those resulting from JV administration of glucose. A significant
overall effect was found (F=27.6, p,0.0001, one-way ANOVA)
and pair-wise comparisons relative to oral 15% glucose revealed
differences for JV 22.5% (220619.2, t=3.6, p,0.001) and 50%
glucose (315633.6, t=7, p,0.001), but not relative to 5% glucose
(8461.8, t=0.3, p.0.05; post-hoc Bonferroni t-tests). C. Mean
glycemia after HPV (9365.9) and JV administration of 5%
glucose was not significantly different (t=1.7, p=0.13, unpaired t-
test). D–F. Similar results were found when peak, rather than
mean glycemia, was compared. No differences were found
between 5% and 15% glucose (9762.5 vs. 10264.3 respectively,
t=0.87, p=0.42, unpaired t-test; D). In comparisons between oral
15% glucose and JV administration of glucose, a significant overall
effect was found (F=34.4, p,0.0001, one-way ANOVA) and
pair-wise comparisons revealed differences relative to JV 22.5%
(319626.3, t=4.9, p,0.001) and 50% glucose (424642.1, t=8,
p,0.001), but not relative to 5% glucose (11066.5, t=0.2,
p.0.05; post-hoc Bonferroni t-tests; E). Finally, peak glycemia
after HPV (9365.9) and JV administration of 5% glucose was not
significantly different (t=2, p=0.08, unpaired t-test, F).
(TIF)
Figure S3 Mean tail blood glycemia (% baseline)
measurements in awake animals. Glycemia data shown
above (Fig. S2), was also analyzed after normalization to baseline
(% baseline; also see Figs. 2B, 2C and 3B for peak values) A. In
animals conditioned orally, differences were not found for mean
glycemia after 5% and 15% glucose (10064.2 vs. 12167.3,
t=2.3, p=0.07, unpaired t-test). B. Mean glycemia after oral
15% glucose, which was effective in conditioning side-bias
reversal, was also compared to those resulting from JV
administration of glucose. A significant overall effect was found
(F=20.8, p,0.0001, one-way ANOVA) and pair-wise compari-
sons relative to oral 15% glucose revealed differences for JV 22.5%
(296629.4, t=3.6, p,0.01) and 50% glucose (402646.2, t=6.3,
p,0.001), but not relative to 5% glucose (13066.4, t=0.2,
p.0.05; post-hoc Bonferroni t-tests). C. Mean glycemia after
HPV (12166.6) and JV administration of 5% glucose was not
significantly different (t=1, p=0.33, unpaired t-test).
(TIF)
Figure S4 Dopamine transient duration and amplitude
in the nucleus accumbens of anesthetized rats, after
glucose or vehicle administration in the hepatic-portal
or jugular vein. Fast-scan cyclic voltammetry was used to
identify spontaneous dopamine release events (transients) in the
nucleus accumbens shell of anesthetized rats. Measurements were
conducted for a baseline period, and also during and after infusion
of 5% glucose in the JV (n=4) or HPV (n=4), or vehicle in the
latter (n=4). Glucose infusion in the HPV, but not the JV, was
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compared to the effect of vehicle infusion in the HPV (see Fig. 5).
A. Here we show transient duration (msec.) prior to infusion
(baseline) and in 5 min bins following infusion onset, for HPV
vehicle (baseline, 4646204; 5 minutes,3716117; 10 minutes,
316629; 15 minutes, 350674; 20 minutes, 402682; blue
squares), HPV glucose (baseline, 548679; 5 minutes, 437648;
10 minutes, 416634; 15 minutes, 434661; 20 minutes, 474661;
red squares) and JV glucose (baseline, 5346120; 5 minutes,
5076142; 10 minutes, 464641; 15 minutes, 3966108; 20 min-
utes, 493697; black squares). Two-way ANOVA revealed the
absence of any significant effects for treatment (F=1.6, p=0.21),
time (F=0.9, p=0.49) and the interaction between these factors
(F=0.08, p=1). B. For transient amplitude (nM) the values for
HPV vehicle (baseline, 35.967.4; 5 minutes, 32.867.1; 10 min-
utes, 29.767; 15 minutes, 26.565.3; 20 minutes, 24.463.3), HPV
glucose (baseline, 29.367.7; 5 minutes, 26.664.4; 10 minutes,
30.264.8; 15 minutes, 26.563.7; 20 minutes, 23.163.4) and JV
glucose (baseline, 26.361.2; 5 minutes, 21.761.8; 10 minutes,
24.961.8; 15 minutes, 25.961.2; 20 minutes, 25.863.4) were also
compared using two-way ANOVA, and no effects were found for
treatment (F=1.4, p=0.25), time (F=0.7, p=0.58) and the
interaction between these factors (F=0.4, p=0.91).
(TIF)
Figure S5 Dopamine transient frequency, duration and
amplitude, in the nucleus accumbens of anesthetized
rats, after systemic cocaine administration. To determine
if the selected dopamine release site was responsive to dopamine
uptake inhibition, once the effects of glucose administration on
nucleus accumbens dopamine transients had been measured,
15 mg/kg cocaine was administered through an intraperitoneal
injection. In 4 animals, transient frequency had degraded or was
unstable. Data for the remaining 8 rats is presented together,
irrespective of treatment group. Repeated-measures one-way
ANOVA was used to investigate possible changes in transient
frequency, duration and amplitude in 5-minute-long time intervals
following i.p. injection, when compared to the baseline period
immediately prior to cocaine injection. A. Cocaine had an overall
effect of increasing transient frequency (F=3.8, p=0.007) with a
significant effect in comparison to baseline (2.260.7 transients/
min) at 20 minutes (762.1, t=3.3, p,0.05), but not the remaining
time points (5 minutes, 2.260.7, t=0.004; 10 minutes, 4.561.3,
t=1.5; 15 minutes, 5.961.8, t=2.5; 25 minutes, 5.961.6, t=2.5;
p.0.05 for all; post-hoc Bonferroni t-tests). B. For transient
duration, cocaine also had an overall significant effect (F=4,
p=0.006), with further significant effects in comparison to
baseline (423632 msec) at 10 minutes (7116122, t=3.4,
p,0.01), 15 minutes (7366126, t=3.7, p,0.01), 20 minutes
(700665, t=3.3, p,0.05) and 25 minutes, 705676, t=3.4,
p,0.01), but not at 5 minutes (600684, t=2.1; p.0.05; post-
hoc Bonferroni t-tests). C. The effects of cocaine on transient
amplitude were not significant, both overall (F=1.3, p=0.31) and
when each time-point was compared to baseline (21.262.4 nM;
5 minutes, 23.761.9, t=1.1; 10 minutes, 25.563.8, t=1.9;
15 minutes, 26.563.2, t=2.3; 20 minutes, 23.961.8, t=1.2;
25 minutes, 23.662, t=1.1; p.0.05 for all; post-hoc Bonferroni
t-tests).
(TIF)
Table S1 Tail blood glycemia (mg/dL) measurements
in awake animals. Rats were allowed to drink water with
simultaneous administration of one of the glucose solutions used
for conditioning (5% or 15% orally, 5%, 22.5% or 50% in the JV
or 5% in the HPV). Glycemia was measured from tail blood at the
start (baseline) and end (09) of the 10 minute-long behavioral
session, and every 10 minutes thereafter (109–409).Glycemia (mg/
dL) was compared using repeated-measures two-way ANOVA,
revealing significant overall effects for stimulus (JV vs. HPV vs.
oral 5% glucose vs. oral 15% glucose vs. JV 22.5% glucose vs. JV
50% glucose; F=25.4, p,0.0001), time (baseline vs. 09 vs. 109 vs.
209 vs. 309 vs. 409; F=42.24, p,0.0001) and the interaction
between these factors (F=12.5, p,0.0001). Further comparisons
were performed at each time-point between glycemia after JV 5%
glucose, considered as a control stimulus that did not condition
side-bias reversal, and glycemia measured after each of the
remaining glucose stimuli (see details in this table). Given the
significant interaction, data was also analyzed separately for each
stimulus, showing a significant effect for time in all cases (JV 5%
glucose, F=14.48, p,0.0001; JV 22.5% glucose, F=19.98,
p,0.0001; JV 50% glucose, F=28.04, p,0.0001; oral 15%
glucose, F=3.212, p=0.036; HPV 5% glucose, F=26.7,
p,0.0001) with the exception of oral 5% glucose (F=2.68,
p=0.087; repeated-measures one-way ANOVA). Finally, glyce-
mia at each time-point was compared to the respective baseline
measure (see details in this table). Significant comparisons are
emphasized as bold text. (basel. – baseline).
(DOC)
Table S2 Blood glycemia (mg/dL) measurements in
anesthetized animals. Rats were anesthetized and then
injected with vehicle or one of the different glucose solutions used
for conditioning through duodenal (water, n=5; 5% glucose,
n=4; 15% glucose, n=6), JV (saline, n=5; 5% glucose, n=6;
22.5% glucose, n=4; 50% glucose, n=4) or HPV (saline, n=4;
5% glucose, n=7) catheters. Glycemia was measured from both
tail and HPV blood at the start (baseline) and end (09) of the
stimulus perfusion, and every 10 minutes thereafter (109–509).
Initially, data were analyzed separately for vehicle and glucose
injections and for tail and HPV blood glycemia. A. For tail blood
glycemia measurements after vehicle injections, a significant
overall effect was found for time (baseline vs. 09 vs. 109 vs. 209
vs. 309 vs. 409 vs. 509; F=2.6, p=0.02) but not for injection site
(JV vs. duodenal vs. HPV; F=0.3, p=0.78) or the interaction
between these factors (F=1.1, p=0.4; repeated-measures two-way
ANOVA). Further comparisons were performed at each time-
point between glycemia after JV saline and that observed after
duodenal water or HPV saline (see details in this table). B. With
HPV blood glycemia measurements after vehicle injections,
significant overall effects were not found for time (F=1,
p=0.41), injection site (F=1.3, p=0.31) nor the interaction
between these factors (F=1.9, p=0.05; repeated-measures two-
way ANOVA). Again, comparisons were performed at each time-
point between glycemia after JV saline and that observed after
other routes of vehicle administration (see details in this table). C.
Relative to tail blood glycemia measurements after glucose
injections, a significant overall effect was found for time
(F=129.3, p,0.0001), stimulus (JV vs. HPV vs. oral 5% glucose
vs. oral 15% glucose vs. JV 22.5% glucose vs. JV 50% glucose;
F=45.5, p,0.0001) and the interaction between these factors
(F=30.7, p,0.0001; repeated-measures two-way ANOVA).
Further comparisons were performed at each time-point between
glycemia after JV 5% glucose, considered as a control stimulus
that did not condition side-bias reversal, and that observed after
the remaining glucose stimuli (see details in this table). D. In terms
of HPV blood glycemia measurements after glucose injections, a
significant overall effect was found for time (F=132, p,0.0001),
stimulus (F=15.5, p,0.0001) and the interaction between these
factors (F=27.5, p,0.0001; repeated-measures two-way AN-
OVA). Again, further comparisons were performed at each time-
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those observed after the remaining glucose stimuli (see details in
this table). Significant comparisons are emphasized as bold text.
(basel. – baseline; dd. – duodenal; sal. – saline; wat. - water).
(DOC)
Table S3 Mean and peak blood glycemia (mg/dL) in
anesthetized animals. Tail and HPV blood glycemia mea-
surements in anesthetized rats (see Table S2) were also analyzed
according to mean and peak values after glucose or vehicle
administration (i.e., 09–509). Since, as described above, no overall
differences in glycemia were found according to the different
routes of vehicle administration, data for vehicle was included as a
single category. Glucose stimuli that previously were not shown to
be effective in conditioning side-bias reversal are emphasized with
bold text. A. Mean glycemia was compared using repeated-
measures two-way ANOVA, revealing significant overall effects for
stimulus (JV vs. HPV vs. duodenal 5% glucose vs. duodenal 15%
glucose vs. JV 22.5% glucose vs. JV 50% glucose vs. vehicle;
F=47.56, p,0.0001), blood territory (tail vs. HPV; F=13.44,
p=0.0007) and the interaction between these factors (F=25.2,
p,0.0001). Significant differences between tail and HPV glycemia
were also found for several individual stimuli (see details in this
table). Given the significant interaction between factors, tail and
HPV glycemia were analyzed separately and, in both cases, overall
significant differences were found (respectively: F=66.26,
p,0.0001; F=31.84, p,0.0001; one-way ANOVA). Further
pair-wise comparisons were also performed separately for tail and
HPV blood between glycemia measurements after JV 5% glucose,
considered as a control stimulus that did not condition side-bias
reversal, and those observed after the remaining glucose stimuli.
For tail blood measurements, such differences were found for JV
22.5% and 50% glucose and vehicle, while for HPV blood
measurements differences were found for duodenal 15% glucose
and JV 22.5% and 50% glucose (see details in this table). B. Peak
glycemia was compared using the same methodologies. We found
significant overall effects for stimulus (F=160.1, p,0.0001), blood
territory (F=32.22, p,0.0001) and the interaction between these
factors (F=10.46, p,0.0001; repeated-measures two-way AN-
OVA), and also significant differences between tail and HPV
glycemia for several stimuli (see table). Again, for both tail and
HPV glycemia, overall significant differences were found (respec-
tively: F=154.8, p,0.0001; F=93.98, p,0.0001; one-way
ANOVA). For tail blood measurements, duodenal 5% glucose,
JV 22.5% and 50% glucose and vehicle differed significantly from
JV 5% glucose, while for HPV blood measurements, differences
were found for vehicle, HPV 5% glucose, duodenal 15% glucose
and JV 22.5% and 50% glucose. In the latter case, duodenal 5%
glucose, the only other glucose stimulus that did not condition
side-bias reversal in awake animals, was the only tested stimulus
that did not significantly differ from JV 5% glucose (see details in
this table). Significant comparisons are emphasized as bold text.
(dd. – duodenal).
(DOC)
Table S4 Mean and peak blood glycemia (% baseline) in
anesthetized animals. Mean and peak tail and HPV blood
glycemia were also compared using values normalized to baseline
measures (% of baseline; see Tables S2 and S3). Again, glucose
stimuli that previously were not shown to be effective in
conditioning side-bias reversal are emphasized with bold text. A.
For mean relative glycemia we found significant overall effects for
stimulus (F=61.8, p,0.0001), blood territory (F=10.98,
p=0.002) and the interaction between these factors (F=21.45,
p,0.0001; repeated-measures two-way ANOVA), and significant
differences between tail and HPV glycemia were found for several
specific stimuli (see details in this table). Given the significant
interaction between factors, tail and HPV glycemia were also
analyzed separately and overall significant effects were found for
both tail blood (F=78.37, p,0.0001) and HPV blood measure-
ments (F=39.95, p,0.0001; repeated measures one-way AN-
OVA). As done previously, further pair-wise comparisons were
performed between glycemia measurements after JV 5% glucose,
considered as a control stimulus that did not condition side-bias
reversal, and those observed after the remaining glucose stimuli.
For tail blood, JV 22.5% and 50% glucose were significantly
different, while for HPV blood, differences were found for HPV
5% glucose, duodenal 5% and 15% glucose and JV 22.5% and
50% (see table). B. For peak relative glycemia, significant main
effects were found for stimulus (F=112.2, p,0.001), blood
territory (F=29.6, p,0.001) and the interaction between these
factors (F=11.4, p,0.001; repeated-measures two-way ANOVA),
and also for several specific stimuli between tail and HPV glycemia
(see details in this table). Given the significant interaction between
factors, tail and HPV glycemia were analyzed separately and, in
both cases, significant differences were found (respectively:
F=85.92, p,0.001 and F=92.8, p,0.001; repeated-measures
one-way ANOVA). Furthermore, for tail blood measurements,
only JV 22.5% and 50% glucose and vehicle differed significantly
from JV 5% glucose, while for HPV blood measurements
differences were found for all stimuli except duodenal 5% glucose,
the only other glucose stimulus that did not result in side-bias
reversal (see details in this table). Significant comparisons are
emphasized as bold text. (dd. – duodenal).
(DOC)
Table S5 Dopamine transient frequency in the nucleus
accumbens of anesthetized rats, after glucose or vehicle
administration in the hepatic-portal or jugular vein.
Fast-scan cyclic voltammetry was used to identify spontaneous
dopamine release events or ‘‘transients’’ in the nucleus accumbens
shell of anesthetized rats. Measurements were conducted for a
baseline period, and also during and after infusion of 5% glucose
in the JV (n=4) or HPV (n=4), or vehicle in the latter (n=4).
Glucose infusion in the HPV, but not the JV, was shown to cause
an increase in dopamine transient frequency, when compared to
the effect of vehicle infusion in the HPV and also the respective
baseline values (also see Fig. 5). Significant comparisons are
emphasized as bold text. (sal. – saline).
(DOC)
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